Cite

HARVARD Citation

    Fleischmann, R. et al. (2021). Long-term safety and efficacy of sarilumab over 5 years in patients with rheumatoid arthritis refractory to TNF inhibitors. Rheumatology. pp. 4991-5001. [Online]. 
  
Back to record